Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects

Edo Kon(Tel Aviv University), Dan Peer(Tel Aviv University)
Nature Reviews Clinical Oncology
August 16, 2023
10.1038/s41571-023-00811-9
Cited by 319

Related Papers

Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
|Bioengineering & Translational Medicine|2021|352
Therapeutic gene silencing of <i>CKAP5</i> leads to lethality in genetically unstable cancer cells
|Science Advances|2023|19
Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics
|Advanced Science|2024|17
Therapeutic Gene Silencing of CKAP5 leads to lethality in genetically unstable cancer cells.
|Research Square|2022|2
Contributors
|Elsevier eBooks|2022|0